Method for monitoring the effect of cancer therapies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 11, 2002
app pub date -
Jun 26, 2001
filing date -
Jun 26, 2000
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
A method for monitoring the effect of cancer therapies with growth factor inhibitors and intracellular signal transduction modulators (,,growth factor cancer drugs'), which act by interfering with overexpression of normal or mutated forms of growth factor receptors, the overproduction of growth factors or defects in the signalling cascade downstream the activated growth factor receptors. The method is based on measuring telomerase activity in a sample from an individual diagnosed for cancer and treated with the growth factor cancer drug and correlating a reduction of telomerase activity with a favorable therapeutic intervention with the drug.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
BOEHRINGER INGELHEIM GMBH | GERMANY'S RHINE RIVER INGELHEIM |
International Classification(s)
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Van, Meel Jacobus | Modling, AT | 7 | 96 |
# of filed Patents : 7 Total Citations : 96 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 4 Citation Count
- C12Q Class
- 3.14 % this patent is cited more than
- 23 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
